METASTATIC SQUAMOUS CELL CARCINOMA
Clinical trials for METASTATIC SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New weekly combo may offer hope for head and neck cancer patients who can't take standard chemo
Disease control Recruiting nowThis study tests a weekly treatment of two chemotherapy drugs (carboplatin and paclitaxel) plus an immunotherapy drug (pembrolizumab) in 32 people with advanced head and neck cancer that has spread. It is for patients who cannot take the standard drug 5-fluorouracil. The goal is …
Matched conditions: METASTATIC SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New triple-drug attack targets hard-to-treat head and neck cancers
Disease control Recruiting nowThis early-phase study tests a new three-drug combination (zanzalintinib, pembrolizumab, and cetuximab) in adults with recurrent or metastatic head and neck cancer that cannot be cured by local treatments. The main goal is to find the safest dose and check for early signs of tumo…
Matched conditions: METASTATIC SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
New dosing strategy for chemo drug aims to improve outcomes in Tough-to-Treat head and neck cancer
Disease control Recruiting nowThis study tests two different schedules of the chemotherapy drug 5-FU in people with advanced head and neck cancer that has not responded to prior treatments. About 46 participants will receive the drug either over two days every two weeks or over four days every three weeks. Th…
Matched conditions: METASTATIC SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 13, 2026 15:59 UTC